Andre La Gerche
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Recognitions
Andre La Gerche has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
- Guido Claessen
KU Leuven
55 shared publications Hein Heidbuchel
44 shared publicationsDavid L. Prior
Department of Medicine, University of Melbourne, Parkville, Victoria, Australia; Cardiology Department, St Vincent's Hospital Melbourne, Fitzroy, Victoria, Australia
31 shared publications- Erin J. Howden
Baker Heart and Diabetes Institute
23 shared publications - Stephen J. Foulkes
University of Alberta
23 shared publications - Hein Heidbuchel
Department of Cardiology, Antwerp University Hospital , Antwerp
22 shared publications
Latest Publications
- Open Access
- 1 December 2026
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 331 (6) , H2028-H2038
Orthostatic and exercise intolerance in postacute sequelae of COVID-19 occur with intact sympathetic neural control and preserved cardiac reserve
Muscle sympathetic nerve activity (MSNA), sympathetic baroreflex gain, and neurovascular transduction were intact in people with postacute sequelae of COVID-19 syndrome (PASC), and MSNA was recruited normally during head-up tilt. However, 41% of participants could not complete the tilt. Biventricular contractile reserve was likewise preserved. Symptoms that track neither sympathetic outflow nor systemic pressure localize the disturbance upstream, to afferent reflex control, or downstream to the cerebral circulation.
- 1 December 2026
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 331 (6) , H2028-H2038
Open AccessOrthostatic and exercise intolerance in postacute sequelae of COVID-19 occur with intact sympathetic neural control and preserved cardiac reserve
Muscle sympathetic nerve activity (MSNA), sympathetic baroreflex gain, and neurovascular transduction were intact in people with postacute sequelae of COVID-19 syndrome (PASC), and MSNA was recruited normally during head-up tilt. However, 41% of participants could not complete the tilt. Biventricular contractile reserve was likewise preserved. Symptoms that track neither sympathetic outflow nor systemic pressure localize the disturbance upstream, to afferent reflex control, or downstream to the cerebral circulation.
- Open Access
- 7 November 2026
- Published by Elsevier in JACC: Clinical Electrophysiology
Defining the contributors to sudden cardiac death in sarcoidosis: a nationwide study
- 7 November 2026
- Published by Elsevier in JACC: Clinical Electrophysiology
Open AccessDefining the contributors to sudden cardiac death in sarcoidosis: a nationwide study
- Open Access
- 6 October 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (19)
Temporal Association Between Exercise and Arrhythmia Episodes in Endurance Athletes With Paroxysmal Atrial Fibrillation
Background: Atrial fibrillation (AF) is a prevalent arrhythmia in endurance athletes, and many athletes report exercise as a trigger for AF episodes. We aimed to investigate the association between exercise sessions and arrhythmia episodes in endurance athletes with paroxysmal AF. Methods: In endurance athletes diagnosed with paroxysmal AF, we continuously monitored arrhythmia episodes using insertable cardiac monitors and report event rates per 24 hours and temporal relation of arrhythmias with exercise sessions. Sports watches and chest straps were used for exercise monitoring. Exercise with a heart rate of 76% to 84% and ≥ 85% of the individual maximum heart rate was classified as high and very high intensity, respectively. Results: Forty‐seven athletes (age 57±10, range 33–75 years, 3 women) were monitored with insertable cardiac monitors for a total of 55 994 hours (median 1008 [840–1344] equaling 42 days [35–56]) and performed a total of 1722 hours of exercise, of which 592 hours at high or very high intensity. Thirty‐one athletes (66%) had a total of 1445 (median 17 [3–33]) AF episodes during monitoring. Thirteen athletes (27%) had AF during exercise of whom 2 had AF during high‐intensity sessions. The event rate of AF was not higher during (0.34 per 24 hours [95% CI, 0.13–0.65]) or subsequently following an exercise session (0.37 [95% CI, 0.10–0.71]), compared with unrelated to exercise (>3 hours after, 0.61 [95% CI, 0.26–1.13]). There were no episodes of exercise‐related ventricular tachycardia. Conclusions: In this study on endurance athletes with paroxysmal AF, the rate of AF episodes was not increased during or subsequently following exercise sessions. Registration: URL: Study Details: NCT04991337. Effects of Detraining in Endurance Athletes With Atrial Fibrillation. ClinicalTrials.gov (NEXAF Detraining).
- 6 October 2026
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 15 (19)
Open AccessTemporal Association Between Exercise and Arrhythmia Episodes in Endurance Athletes With Paroxysmal Atrial Fibrillation
Background: Atrial fibrillation (AF) is a prevalent arrhythmia in endurance athletes, and many athletes report exercise as a trigger for AF episodes. We aimed to investigate the association between exercise sessions and arrhythmia episodes in endurance athletes with paroxysmal AF. Methods: In endurance athletes diagnosed with paroxysmal AF, we continuously monitored arrhythmia episodes using insertable cardiac monitors and report event rates per 24 hours and temporal relation of arrhythmias with exercise sessions. Sports watches and chest straps were used for exercise monitoring. Exercise with a heart rate of 76% to 84% and ≥ 85% of the individual maximum heart rate was classified as high and very high intensity, respectively. Results: Forty‐seven athletes (age 57±10, range 33–75 years, 3 women) were monitored with insertable cardiac monitors for a total of 55 994 hours (median 1008 [840–1344] equaling 42 days [35–56]) and performed a total of 1722 hours of exercise, of which 592 hours at high or very high intensity. Thirty‐one athletes (66%) had a total of 1445 (median 17 [3–33]) AF episodes during monitoring. Thirteen athletes (27%) had AF during exercise of whom 2 had AF during high‐intensity sessions. The event rate of AF was not higher during (0.34 per 24 hours [95% CI, 0.13–0.65]) or subsequently following an exercise session (0.37 [95% CI, 0.10–0.71]), compared with unrelated to exercise (>3 hours after, 0.61 [95% CI, 0.26–1.13]). There were no episodes of exercise‐related ventricular tachycardia. Conclusions: In this study on endurance athletes with paroxysmal AF, the rate of AF episodes was not increased during or subsequently following exercise sessions. Registration: URL: Study Details: NCT04991337. Effects of Detraining in Endurance Athletes With Atrial Fibrillation. ClinicalTrials.gov (NEXAF Detraining).
- Open Access
- 25 July 2026
- Published by Elsevier in American Journal of Preventive Cardiology
- Vol. 31
Carotid atherosclerosis and aortic stiffness in masters athletes: Multimodality vascular phenotyping from the Master@Heart study
- 25 July 2026
- Published by Elsevier in American Journal of Preventive Cardiology
- Vol. 31
Open AccessCarotid atherosclerosis and aortic stiffness in masters athletes: Multimodality vascular phenotyping from the Master@Heart study
- Open Access
- 18 July 2026
- Published by Elsevier in American Journal of Preventive Cardiology
- Vol. 31
Acute strenuous exercise does not meaningfully influence lipoprotein(a)-based cardiovascular risk classification in endurance athletes
- 18 July 2026
- Published by Elsevier in American Journal of Preventive Cardiology
- Vol. 31
Open AccessAcute strenuous exercise does not meaningfully influence lipoprotein(a)-based cardiovascular risk classification in endurance athletes
- 23 June 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 27 (8) , 1469-1497
Indications, protocols, and interpretation of cardiovascular imaging for the evaluation and management of athletes. A Clinical Consensus Statement of the European Association of Preventive Cardiology (EAPC) and the European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology (ESC). Part 2—Cardiovascular Magnetic Resonance, Cardiac CT and Nuclear Imaging
The number of individuals engaging in sports continues to rise, and identifying those with cardiac substrates associated with increased risk of exercise-related adverse events is crucial. Athlete evaluation requires a refined diagnostic strategy to distinguish physiological cardiac remodelling from pathology. This joint European Association of Preventive Cardiology/European Association of Cardiovascular Imaging consensus provides a multimodality approach for advanced cardiovascular imaging in sports cardiology. Cardiovascular magnetic resonance, cardiac computed tomography, and nuclear imaging each offer complementary insights into cardiac structure, function, coronary anatomy, tissue characterization, perfusion, and inflammation. When integrated with clinical data and first-line tests, they improve diagnostic precision and risk stratification in scenarios frequently encountered in athletes, including ventricular arrhythmias, cardiomyopathies, congenital coronary anomalies, inflammatory myocardial disease, and coronary artery disease. Standardized protocols tailored to age, training, and clinical indication are essential to ensure reliability and avoid misinterpreting physiological adaptation as disease. The consensus emphasizes responsible reporting, considering performance and legal implications of diagnoses, and recommends second-line imaging when justified. Functional imaging, for ischaemia or inflammation, is central in guiding return-to-play decisions. Persistent evidence gaps include limited normative datasets across athletic subgroups and uncertain significance of subtle tissue abnormalities. Overall, this consensus supports harmonized, safe, and judicious multimodality imaging to protect athletes while preventing unnecessary sport restriction.
- 23 June 2026
- Published by Oxford University Press (OUP) in European Heart Journal - Cardiovascular Imaging
- Vol. 27 (8) , 1469-1497
Indications, protocols, and interpretation of cardiovascular imaging for the evaluation and management of athletes. A Clinical Consensus Statement of the European Association of Preventive Cardiology (EAPC) and the European Association of Cardiovascular Imaging (EACVI) of the European Society of Cardiology (ESC). Part 2—Cardiovascular Magnetic Resonance, Cardiac CT and Nuclear Imaging
The number of individuals engaging in sports continues to rise, and identifying those with cardiac substrates associated with increased risk of exercise-related adverse events is crucial. Athlete evaluation requires a refined diagnostic strategy to distinguish physiological cardiac remodelling from pathology. This joint European Association of Preventive Cardiology/European Association of Cardiovascular Imaging consensus provides a multimodality approach for advanced cardiovascular imaging in sports cardiology. Cardiovascular magnetic resonance, cardiac computed tomography, and nuclear imaging each offer complementary insights into cardiac structure, function, coronary anatomy, tissue characterization, perfusion, and inflammation. When integrated with clinical data and first-line tests, they improve diagnostic precision and risk stratification in scenarios frequently encountered in athletes, including ventricular arrhythmias, cardiomyopathies, congenital coronary anomalies, inflammatory myocardial disease, and coronary artery disease. Standardized protocols tailored to age, training, and clinical indication are essential to ensure reliability and avoid misinterpreting physiological adaptation as disease. The consensus emphasizes responsible reporting, considering performance and legal implications of diagnoses, and recommends second-line imaging when justified. Functional imaging, for ischaemia or inflammation, is central in guiding return-to-play decisions. Persistent evidence gaps include limited normative datasets across athletic subgroups and uncertain significance of subtle tissue abnormalities. Overall, this consensus supports harmonized, safe, and judicious multimodality imaging to protect athletes while preventing unnecessary sport restriction.
- 11 June 2026
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
Impaired Peripheral Oxygen Diffusion is the Primary Determinant of Exercise Intolerance in High-risk Older Breast Cancer Survivors
Background: Peak oxygen uptake (V̇O 2 peak) is a strong predictor of survival in breast cancer survivors (BCS), with values ≤1.09 L/min associated with increased mortality. The relative contributions of convective oxygen delivery (QO 2 ) and muscle oxygen diffusing capacity (D M O 2 ) to reduced V̇O 2 peak in BCS remain unclear. Materials and Methods: In 49 BCS, we measured V̇O 2 peak from cycle ergometry with gas-exchange analysis, and derived QO 2 and D M O 2 using Fick-based calculations and computational modeling. BCS were stratified by mortality risk: High-Risk (V̇O 2 peak ≤1.09 L/min; n=11) and Lower-Risk (n=38), and compared using t-tests, Mann-Whitney U tests and ANCOVA. Dominance analysis quantified the relative contributions of QO 2 and D M O 2 to V̇O 2 peak within each group. Results: The High-Risk group was older (72±6 vs. 69±5 years), had longer time since treatment (17±5 vs. 13±6 years), and higher cumulative doxorubicin-equivalent doses (291±134 vs. 163±120 mg/m²)(all p≤0.05). After ANCOVA, the High-Risk group had lower V̇O 2 peak (1.0±0.1 vs. 1.4±0.2 L/min), QO 2 (1.8±0.3 vs. 2.5±0.5 L/min), and D M O 2 (28.2±4.8 vs. 41.5±9.0 mL/min/mmHg) (all p≤0.001). Dominance analysis revealed D M O 2 as the strongest contributor to V̇O 2 peak with 81.7% and 66.0% of explained variance in High-Risk and Lower-Risk groups while QO 2 accounted for 14.1% and 30.3%, respectively. Conclusions: In older, long-term BCS with reduced V̇O 2 peak (≤1.09 L/min), impairments in both QO 2 and D M O 2 contribute to reduced exercise tolerance. However, D m O 2 emerged as the strongest modeled contributor in the high-risk group. Interventions prioritizing skeletal muscle–vascular function, alongside complementary targeting of QO 2 , may have greater impact on V̇O 2 peak improvements and survival in this high-risk population.
- 11 June 2026
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
Impaired Peripheral Oxygen Diffusion is the Primary Determinant of Exercise Intolerance in High-risk Older Breast Cancer Survivors
Background: Peak oxygen uptake (V̇O 2 peak) is a strong predictor of survival in breast cancer survivors (BCS), with values ≤1.09 L/min associated with increased mortality. The relative contributions of convective oxygen delivery (QO 2 ) and muscle oxygen diffusing capacity (D M O 2 ) to reduced V̇O 2 peak in BCS remain unclear. Materials and Methods: In 49 BCS, we measured V̇O 2 peak from cycle ergometry with gas-exchange analysis, and derived QO 2 and D M O 2 using Fick-based calculations and computational modeling. BCS were stratified by mortality risk: High-Risk (V̇O 2 peak ≤1.09 L/min; n=11) and Lower-Risk (n=38), and compared using t-tests, Mann-Whitney U tests and ANCOVA. Dominance analysis quantified the relative contributions of QO 2 and D M O 2 to V̇O 2 peak within each group. Results: The High-Risk group was older (72±6 vs. 69±5 years), had longer time since treatment (17±5 vs. 13±6 years), and higher cumulative doxorubicin-equivalent doses (291±134 vs. 163±120 mg/m²)(all p≤0.05). After ANCOVA, the High-Risk group had lower V̇O 2 peak (1.0±0.1 vs. 1.4±0.2 L/min), QO 2 (1.8±0.3 vs. 2.5±0.5 L/min), and D M O 2 (28.2±4.8 vs. 41.5±9.0 mL/min/mmHg) (all p≤0.001). Dominance analysis revealed D M O 2 as the strongest contributor to V̇O 2 peak with 81.7% and 66.0% of explained variance in High-Risk and Lower-Risk groups while QO 2 accounted for 14.1% and 30.3%, respectively. Conclusions: In older, long-term BCS with reduced V̇O 2 peak (≤1.09 L/min), impairments in both QO 2 and D M O 2 contribute to reduced exercise tolerance. However, D m O 2 emerged as the strongest modeled contributor in the high-risk group. Interventions prioritizing skeletal muscle–vascular function, alongside complementary targeting of QO 2 , may have greater impact on V̇O 2 peak improvements and survival in this high-risk population.
- 1 June 2026
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 140 (6) , 1697-1710
From healthy to heart failure in 24 hours: defining the upper limit of exercise-induced cardiac fatigue
This case study of a highly trained ultra-endurance athlete performing two world-record setting 12 and 24 h cycling bouts provides the most definitive illustration that a sufficiently intense and prolonged dose of exercise (in this case, 24 h of intense cycling) can result in acute heart failure. The absence of persistent myocardial injury highlights the remarkable resilience of the cardiovascular system to acute stress and reinforces the importance of adequate recovery following prolonged and intensive endurance exercise bouts.
- 1 June 2026
- Published by American Physiological Society in Journal of Applied Physiology
- Vol. 140 (6) , 1697-1710
From healthy to heart failure in 24 hours: defining the upper limit of exercise-induced cardiac fatigue
This case study of a highly trained ultra-endurance athlete performing two world-record setting 12 and 24 h cycling bouts provides the most definitive illustration that a sufficiently intense and prolonged dose of exercise (in this case, 24 h of intense cycling) can result in acute heart failure. The absence of persistent myocardial injury highlights the remarkable resilience of the cardiovascular system to acute stress and reinforces the importance of adequate recovery following prolonged and intensive endurance exercise bouts.
- 1 June 2026
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 330 (6) , H1841-H1852
Absolute and workload-indexed exercise blood pressure responses: associations with cardiac output, vascular resistance, and cardiorespiratory fitness in females
In females, a higher workload-indexed systolic blood pressure (SBP/W)-slope during exercise was associated with greater peripheral vascular resistance, lower cardiac output, and lower cardiorespiratory fitness, irrespective of maximal systolic blood pressure (SBP max ). In contrast, an exaggerated SBP max alone reflected differing contributions of increased flow (i.e., cardiac output) or increased vascular resistance across individuals. Evaluating the SBP/W-slope provides a more physiologically informed interpretation of exercise blood pressure and may improve identification of females with impaired pressure-flow regulation and reduced cardiovascular reserve.
- 1 June 2026
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 330 (6) , H1841-H1852
Absolute and workload-indexed exercise blood pressure responses: associations with cardiac output, vascular resistance, and cardiorespiratory fitness in females
In females, a higher workload-indexed systolic blood pressure (SBP/W)-slope during exercise was associated with greater peripheral vascular resistance, lower cardiac output, and lower cardiorespiratory fitness, irrespective of maximal systolic blood pressure (SBP max ). In contrast, an exaggerated SBP max alone reflected differing contributions of increased flow (i.e., cardiac output) or increased vascular resistance across individuals. Evaluating the SBP/W-slope provides a more physiologically informed interpretation of exercise blood pressure and may improve identification of females with impaired pressure-flow regulation and reduced cardiovascular reserve.